Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1930 1
1931 1
1932 4
1933 1
1947 1
1951 1
1952 3
1953 2
1954 1
1955 2
1956 3
1957 1
1958 1
1959 1
1962 2
1963 8
1964 4
1965 7
1966 4
1967 9
1968 7
1969 6
1970 9
1971 3
1972 7
1973 4
1974 8
1975 7
1976 4
1977 6
1978 4
1979 4
1980 3
1981 5
1982 11
1983 5
1984 4
1985 6
1986 9
1987 7
1988 7
1989 6
1990 7
1991 3
1992 8
1993 9
1994 13
1995 13
1996 6
1997 6
1998 4
1999 4
2000 4
2001 4
2002 9
2003 9
2004 9
2005 11
2006 9
2007 20
2008 19
2009 28
2010 28
2011 35
2012 43
2013 51
2014 59
2015 55
2016 53
2017 61
2018 68
2019 87
2020 91
2021 97
2022 101
2023 80
2024 81
2025 65

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,293 results

Results by year

Filters applied: . Clear all
Page 1
Elimination of Radiation-Induced Senescence in the Brain Tumor Microenvironment Attenuates Glioblastoma Recurrence.
Fletcher-Sananikone E, Kanji S, Tomimatsu N, Di Cristofaro LFM, Kollipara RK, Saha D, Floyd JR, Sung P, Hromas R, Burns TC, Kittler R, Habib AA, Mukherjee B, Burma S. Fletcher-Sananikone E, et al. Among authors: mukherjee b. Cancer Res. 2021 Dec 1;81(23):5935-5947. doi: 10.1158/0008-5472.CAN-21-0752. Epub 2021 Sep 27. Cancer Res. 2021. PMID: 34580063 Free PMC article.
Promotion of DNA end resection by BRCA1-BARD1 in homologous recombination.
Salunkhe S, Daley JM, Kaur H, Tomimatsu N, Xue C, Raina VB, Jasper AM, Rogers CM, Li W, Zhou S, Mojidra R, Kwon Y, Fang Q, Ji JH, Badamchi Shabestari A, Fitzgerald O, Dinh H, Mukherjee B, Habib AA, Hromas R, Mazin AV, Wasmuth EV, Olsen SK, Libich DS, Zhou D, Zhao W, Greene EC, Burma S, Sung P. Salunkhe S, et al. Among authors: mukherjee b. Nature. 2024 Oct;634(8033):482-491. doi: 10.1038/s41586-024-07910-2. Epub 2024 Sep 11. Nature. 2024. PMID: 39261729 Free PMC article.
Revisiting representativeness.
Lu H, Zivich PN, Rudolph JE, Liew Z, Mukherjee B, Li F. Lu H, et al. Among authors: mukherjee b. Int J Epidemiol. 2025 Jun 11;54(4):dyaf109. doi: 10.1093/ije/dyaf109. Int J Epidemiol. 2025. PMID: 40587415 No abstract available.
Prostaglandin-associated periorbitopathy.
Shrirao N, Khurana M, Mukherjee B. Shrirao N, et al. Among authors: mukherjee b. Indian J Ophthalmol. 2016 Jun;64(6):459. doi: 10.4103/0301-4738.187676. Indian J Ophthalmol. 2016. PMID: 27488155 Free PMC article. No abstract available.
Steatocystoma of the Eyelid.
Mukherjee B. Mukherjee B. Eye (Lond). 2025 May 12. doi: 10.1038/s41433-025-03820-3. Online ahead of print. Eye (Lond). 2025. PMID: 40355706 No abstract available.
Targeting cIAP2 in a novel senolytic strategy prevents glioblastoma recurrence after radiotherapy.
Tomimatsu N, Di Cristofaro LFM, Kanji S, Samentar L, Jordan BR, Kittler R, Habib AA, Espindola-Netto JM, Tchkonia T, Kirkland JL, Burns TC, Sarkaria JN, Gilbert A, Floyd JR, Hromas R, Zhao W, Zhou D, Sung P, Mukherjee B, Burma S. Tomimatsu N, et al. Among authors: mukherjee b. EMBO Mol Med. 2025 Apr;17(4):645-678. doi: 10.1038/s44321-025-00201-x. Epub 2025 Feb 19. EMBO Mol Med. 2025. PMID: 39972068 Free PMC article.
Quantum dots: The cutting-edge nanotheranostics in brain cancer management.
Chakraborty P, Das SS, Dey A, Chakraborty A, Bhattacharyya C, Kandimalla R, Mukherjee B, Gopalakrishnan AV, Singh SK, Kant S, Nand P, Ojha S, Kumar P, Jha NK, Jha SK, Dewanjee S. Chakraborty P, et al. Among authors: mukherjee b. J Control Release. 2022 Oct;350:698-715. doi: 10.1016/j.jconrel.2022.08.047. Epub 2022 Sep 7. J Control Release. 2022. PMID: 36057397 Review.
EpCAM-targeted betulinic acid analogue nanotherapy improves therapeutic efficacy and induces anti-tumorigenic immune response in colorectal cancer tumor microenvironment.
Dutta D, Al Hoque A, Paul B, Park JH, Chowdhury C, Quadir M, Banerjee S, Choudhury A, Laha S, Sepay N, Boro P, Kaipparettu BA, Mukherjee B. Dutta D, et al. Among authors: mukherjee b. J Biomed Sci. 2024 Aug 20;31(1):81. doi: 10.1186/s12929-024-01069-8. J Biomed Sci. 2024. PMID: 39164686 Free PMC article.
1,293 results